Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitis

Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):194-195. doi: 10.55563/clinexprheumatol/7jue09. Epub 2021 Mar 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abatacept / therapeutic use
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation* / adverse effects

Substances

  • Immunosuppressive Agents
  • Abatacept